Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Coronavirus main protease is essential for viral polyprotein processing and replication. Here Vuong et al. report efficient inhibition of SARS-CoV-2 replication by the dipeptide-based protease inhibitor GC376 and its parent GC373, which were originally used to treat feline coronavirus infection.

書目詳細資料

發表在:	Nature Communications
Main Authors:	Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux
格式:	Article
語言:	英语
出版:	Nature Portfolio 2020-08-01
在線閱讀:	https://doi.org/10.1038/s41467-020-18096-2